Vounotrypidis, Efstathios
Hillenmayer, Anna
Wertheimer, Christian M.
Athanasiou, Alexis
Siedlecki, Jakob
Orth, Michael
Ohlmann, Andreas
Priglinger, Siegfried G.
Wolf, Armin
Funding for this research was provided by:
Universitätsklinikum Ulm
Article History
Received: 5 December 2020
Accepted: 24 March 2021
First Online: 13 April 2021
Competing interests
: The authors declare no competing interests. All authors certify that they have no affiliations with -or involvement in-any organization or entity with any financial interest or non-financial interest in the subject matter or materials discussed in this manuscript. Efstathios Vounotrypidis, Anna Hillenmayer, Christian M Wertheimer, Alexis Athanasiou, Michael Orth and Andreas Ohlmann declare that they have no financial interests. Jakob Siedlecki receives speaker and consultant honoraria or research funding from Carl Zeiss and Novartis. Siegfried Priglinger receives speaker and consultant honoraria from and has served on advisory boards for Abbott, Alcon, Geuder, Oculus, Schwind, STAAR, TearLab, Thieme Compliance, Ziemer, Zeiss and research funding from Abbott, Alcon, Hoya, Oculentis, Oculus, Schwind and Zeiss. Armin Wolf receives fees for lectures/consulting or research funding from Novartis Pharma GmbH; Bayer Healthcare AG; Alimera; Allergan; Oertli Instrumente AG; Roche and Appellis<b>.</b>